Cargando…
Cardiotoxicity Induced by Protein Kinase Inhibitors in Patients with Cancer
Kinase inhibitors (KIs) represent a growing class of drugs directed at various protein kinases and used in the treatment of both solid tumors and hematologic malignancies. It is a heterogeneous group of compounds that are widely applied not only in different types of tumors but also in tumors that a...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910876/ https://www.ncbi.nlm.nih.gov/pubmed/35269958 http://dx.doi.org/10.3390/ijms23052815 |